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AfricaBackground: Important investments were made in countries for the polio eradication initiative. On 25
September 2015, a major milestone was achieved when Nigeria was removed from the list of polio-
endemic countries. Routine Immunization, being a key pillar of polio eradication initiative needs to be
strengthened to sustain the gains made in countries. For this, there is a huge potential on building on
the use of polio infrastructure to contribute to RI strengthening.
Methods: We reviewed estimates of immunization coverage as reported by the countries to WHO and
UNICEF for three vaccines: BCG, DTP3 (third dose of diphtheria-tetanus toxoid- pertussis), and the first
dose of measles-containing vaccine (MCV1).We conducted a systematic review of best practices docu-
ments from eight countries which had significant polio eradication activities.
Results: Immunization programmes have improved significantly in the African Region. Regional coverage
for DTP3 vaccine increased from 51% in 1996 to 77% in 2014. DTP3 coverage increased >3 folds in DRC
(18–80%) and Nigeria from 21% to 66%; and >2 folds in Angola (41–87%), Chad (24–46%), and Togo
(42–87%). Coverage for BCG and MCV1 increased in all countries. Of the 47 countries in the region, 18
(38%) achieved a national coverage for DTP3 P90% for 2 years meeting the Global Vaccine Action
(GVAP) target. A decrease was noted in the Ebola-affected countries i.e., Guinea, Liberia and Sierra Leone.
Conclusions: PEI has been associated with increased spending on immunization and the related improve-
ments, especially in the areas of micro planning, service delivery, program management and capacity
building. Continued efforts are needed to mobilize international and domestic support to strengthen
and sustain high-quality immunization services in African countries. Strengthening RI will in turn sustain
the gains made to eradicate poliovirus in the region.
 2016 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction areas, RI efforts are complemented with supplemental immuniza-Significant progress has been made to interrupt wild poliovirus
(WPV) transmission since the 1988 launch of the World Health
Organization (WHO) Global Polio Eradication Initiative (GPEI) by
the World Health Assembly [1]. Global polio eradication was to
be achieved within the Expanded Programme on Immunization
(EPI) and the framework of strengthened primary health care. Rou-
tine immunization (RI) is a key pillar of polio eradication efforts
which aims to ensure that all children receive the recommended
childhood immunizations, including three doses of oral polio vac-
cine (OPV). To enhance population immunity in low coveragetion activities (SIAs) and mass mop-up campaigns which are con-
ducted to administer additional OPV doses to children [2,3].
Since 1988, implementation of the recommended polio eradica-
tion strategies (i.e., strong RI, SIAs and well performing acute flac-
cid paralysis (AFP) surveillance systems) have successfully reduced
the global incidence of polio by 99%. Despite success in interrupt-
ing WPV transmission, several countries in the African region have
experienced widespread polio outbreaks in the recent past. Since
2001, polio outbreaks have occurred in 31 previously polio-free
African countries [4]. Prior to 2015, Nigeria had yet to interrupt
endemicWPV transmission and was the source of WPV responsible
for polio outbreaks in 25 formerly polio-free African countries
[5,6]. An extensive set of outbreak response and preventative SIAs
were conducted in the countries experiencing polio outbreaks. On
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African region when Nigeria was removed from the list of polio-
endemic countries leaving only two countries (i.e., Afghanistan
and Pakistan) that have never interrupted endemic WPV transmis-
sion [7]. This remarkable achievement brings Nigeria and the
African region closer to being certified polio-free and is the result
of an extensive response by domestic and international partners
that saw sizeable investment in human and financial resources
for immunization programs in the region. Objective 2 of the Polio
Eradication and Endgame Strategic Plan 2013–2018 further rein-
forced the resolve to build on build on polio eradication gains,
including infrastructure to strengthen immunization programs,
phased withdrawal of OPV starting with type-2 containing OPV,
and the introduction of inactivated polio vaccine (IPV) into RI pro-
grammes globally [8]. This has inspired discussions on how GPEI
and RI can benefit from each other especially how polio assets
and infrastructure can strengthen RI, and how a strong RI system
can accelerate polio eradication.
With the eradication of polio from the African continent fast
approaching, questions have been raised as to whether polio erad-
ication efforts in the region contributed to strengthening RI in the
African region, especially in those countries with considerable
polio eradication infrastructure. The impact of vertical eradication
programs on health systems has been a much debated topic in
public health [9,10]. Polio eradication activities in the Western
Pacific Region resulted in both successful interruption of wild
poliovirus (WPV) transmission and strengthened routine vaccine
delivery, mainly in previously poor performing countries [11].
Although anecdotal evidence suggests a positive contribution,
there is still little documentation on the impact of polio eradication
initiatives on routine immunization in Africa. This paper examines
the contribution if any of polio eradication activities on RI in eight
African countries which had polio outbreaks in the recent past.
2. Methods
We reviewed the estimates of immunization coverage for each
country as reported by WHO and the United Nations Children’s
Fund (UNICEF) from the online information system, which contains
immunization and surveillance data reported to the WHO African
Regional Office by Member States. The analysis included three
common vaccines in the routine infant immunization schedules
i.e., Bacillus Calmette–Guerin (BCG), the third dose of diphtheria–
tetanus toxoid–pertussis vaccine (DTP3), and the first dose of
measles-containing vaccine (MCV1). DTP3 is used as a proxy for
vaccination coverage and performance [12].
The two modalities of delivering OPV in the African region were
through RI services including Periodic Intensification Routine
activities (PIRI), child health days and also through conducting sev-
eral rounds of polio SIAs. These include national immunization
days (NIDs), subnational immunization days (SNIDs), and mop-
up rounds. Several doses of OPV were administered to a target pop-
ulation of mostly children aged <5 years.
We conducted a systematic review of best practices documents
and other relevant reports from eight countries which had WPV
transmission and which had significant polio eradication activities
(i.e., Angola, Cote D’Ivoire, the Democratic Republic of Congo [DRC],
Ethiopia, Nigeria, Tanzania, Chad, and Togo). The selected best
practices were then grouped into four thematic areas describing
the specific contribution: microplanning, implementation and ser-
vice delivery, capacity building and program management. Best
practices from the eight countries were considered as representa-
tive of all the other AFR Member States. Immunization coverage
trends for DRC, Ethiopia and Nigeria countries were also analyzed
from 1996 when the polio campaigns were introduced in the AFR
after the PEI was launched in 1988.2.1. Microplanning
Polio campaigns have contributed to the identification of settle-
ments or villages with high number of unvaccinated children by
spearheading the development of improved microplans using
innovative technology. Use of global positioning systems (GPS) to
create accurate, coordinate-based maps for polio-endemic states
in Nigeria improved microplans that were consequently utilized
to provide routine vaccines [13].
In almost all the eight countries, polio eradication activities
(PEI) supported exercises to update health facility microplans
named in Nigeria ‘‘reach every ward” (REW microplans) to capture
previously unreached settlements, improving access and utiliza-
tion of the immunization services by reestablishing immunization
service delivery points (fixed sites) in wards with existing facilities
and outreach or mobile sites.
2.2. Implementation and service delivery
Strategies used for unreached children during polio campaigns
were leveraged to ensure RI services are provided in identified
areas. In addition to delivering OPV, the NIDs or SNIDs and child
days were used as opportunities to administer other routine vacci-
nes in all countries in addition to the micronutrient vitamin A.
In DRC, Polio eradication activities facilitated negotiations with
armed groups for the vaccination of children during NIDs and also
during RI outreach sessions in the eastern part of the country
through interpersonal meetings and education of those armed
groups.
A similar situation was observed in Angola where the Angolan
Army Health Services (AAHS) over the past 20 years have been
fully involved in immunization services in hard to reach areas
using helicopters and trucks as well as providing RI services on
daily basis in their military health facilities and hospitals.
In Tanzania, PEI supported use of village health workers during
immunization services in the community.
In Chad, the Ministry of Health worked closely with the
National Program of Health for Nomads (PNSN) and the Ministry
of Livestock and Animal Resources (MERA) to synchronize vaccina-
tion activities for humans as well as cattle and sheep at least twice
a year. Key activities included identifying the movements of
nomads with their seasonal itineraries, identifying leaders and rep-
resentatives of nomads, for advocacy, organizing a multi-sector,
interagency meetings and developing an action plans for immu-
nization of nomadic children and pregnant women.
2.3. Capacity building
Polio funded staff were used to support other public health
activities such as health care worker capacity building activities
in the eight priority countries. These included training of health
workers in all areas of immunization and supportive supervision.
In Ethiopia, polio funds were used to increase the number of
supportive supervision visits to poorly performing zones using an
integrated portable digital assistant (PDA) checklist by WHO field
officers. Officers analyzed and used the data for action at their
level.
Similarly, in Nigeria, PEI contributed to strengthening support-
ive supervision and using text messages to transmit data and drive
corrective actions, known as Nigeria’s Real-time Tracking of
Routine Immunization Supervision (NRTRIS). After cascade
orientation sessions were conducted at national, State and local
government area (LGA) level, the polio staff carried out supportive
supervision to the health facilities on a weekly basis. An abridged
checklist was used to monitor implementation of the planned
immunization sessions.
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visits to polio surge staff and provide on-the-job training, address
staff problems and provide guidance to improve their performance.
Regular meetings were also held between the village committees
and health facility staff to improve linkages and enable good turn-
out during outreach and mobile services. Community trainings
provided an opportunity for field volunteers to support health
workers in revising micro plans to identify new outreach points.
2.4. Program management
In all the eight countries, polio processes, human and financial
resources, vehicles and tools were used in managing other priority
health programmes, mainly routine EPI. The polio funded vehicle
fleet was ‘‘polyvalent” and benefited many other priority health
programs and administration at all levels, especially for surveil-
lance and supervision.
In Chad, PEI led to inception of monthly monitoring and deci-
sion making meetings that took into account not only immuniza-
tion issues but also all existing problems in the health sector.
Health sector decision-making monthly meetings are held at the
regional and central level chaired by the regional governor and
the Head of State respectively.
In Ethiopia, PEI supported orientation meetings with all zonal,
woreda managers on ‘‘reaching every district” (RED) approach;
microplanning and quarterly monitoring review meetings. They
also supported technical development, printing and distribution
of tools to monitor RI programs.BCG
DTP3
MCV
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Fig. 1. Vaccination coverage for BCG, DTP3 and MCIn Tanzania, health workers with experience in polio manage-
ment were recruited to provide RI and other services in an inte-
grated manner in remote villages which lacked adequate health
services.
In Nigeria, funds from the polio program were used by health
facilities to collect vaccines from LGAs and State cold stores
thereby ensuring uninterrupted supply of vaccines at the end
points. We also reviewed RI data from the WHO Africa Regional
Office to put the data from the documentation of the eight coun-
tries in a wider context to establish the contribution of PEI to RI.3. Results
Fig. 1 shows the national trends in infant immunization rates
for BCG, DTP3 and MCV1 from 1989 to 2014 in the three countries.
During this period, there was a gradual increase of the vaccination
coverage in the 3 countries. This trend was observed in the 8 coun-
tries and even all countries in the region as shown on Fig. 2. In DRC
and Nigeria, the coverage of the DTP3 increased more than three-
fold during the same time period i.e., in DRC, from 18% to 80%,
and in Nigeria from 21% to 66%. In Angola, Chad and Togo, the
increase was twofold or more (i.e., Angola 41–87%, Chad: 24–46%
and Togo: 42–87%). A moderate increase was observed in Cote
d’Ivoire (58–67%), Tanzania (82–97%), and Ethiopia (55–77%). A
similar trend was observed for BCG and MCV1.
According to WHO and UNICEF coverage estimates, the regional
coverage for DTP3 vaccine increased from 5% in 1980 to 77% in 
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Fig. 2. Coverage of DTP3, MCV1 and OPV3 vaccines in the African Region, 1980–2014. Source:*WHO/UNICEF estimates.
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Fig. 3. Vaccination coverage by antigen and year WHO/AFR⁄. *WHO/UNICEF estimates. http://www.who.int/immunization/monitoring_surveillance/data/gs_afrprofile.pdf?
ua=1.
Fig. 4. Estimated number of children who did not receive the third dose of pentavalent vaccine during the first year of life among 10 countries in Africa with the largest
number of unimmunized children, and cumulative percentage of all incompletely vaccinated children in Africa, 2013–2014⁄. **WHO/AFRO/FRH/IVD database.
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and even other antigens of the programme (Fig. 3).
In 2014, almost 7.4 million children in Africa missed out on rou-
tine immunization services and 75% of these missed children were
located in 10 countries, with 50% of these children located in
Ethiopia, DRC, Nigeria, and Uganda (Fig. 4). Five of the 10 countries
are among AFR priority countries and receive support for the
development and implementation of national routine immuniza-
tion programs and efforts to reach unreached children.
Table 1 shows that out of the 47 countries in the region, 18
countries (38%) achieved a national coverage for DTP3 containing
vaccine of P90% meeting the Global and Regional Vaccine Action
(GVAP) in 2014 (Table 1). An increase in national vaccination cov-
erage was reported in Ethiopia, DRC and Nigeria while a decrease
was noted in 17 countries, including the three Ebola-affected coun-
tries i.e., Guinea, Liberia and Sierra Leone.
4. Discussion
In our review of the contribution if any of polio eradication
activities on RI in eight African countries which had polioTable 1
Vaccination coverage for EPI antigens by country, WHO/AFR, 2014.*
Countries BCG DTP3 MCV1
Algeria 99 95 95
Angola 81 80 85
Benin 88 70 63
Botswana 98 95 97
Burkina Faso 98 91 88
Burundi 92 95 94
Cabo Verde 99 95 93
Cameroon 82 87 80
CAR 74 47 49
Chad 59 46 54
Comoros 76 80 80
Congo 95 90 80
Côte d’Ivoire 84 67 63
DRC 90 80 77
Equatorial Guinea 71 24 44
Eritrea 97 94 96
Ethiopia 75 77 70
Gabon 91 70 61
Gambia 96 96 96
Ghana 99 98 92
Guinea 72 51 52
Guinea-Bissau 94 80 69
Kenya 81 81 79
Lesotho 87 96 92
Liberia 73 50 58
Madagascar 75 73 64
Malawi 97 91 85
Mali 79 77 80
Mauritania 98 84 84
Mauritius 97 97 98
Mozambique 93 78 85
Namibia 97 88 83
Niger 76 68 72
Nigeria 74 66 51
Rwanda 99 99 98
Sao Tome & Principe 95 95 92
Senegal 95 89 80
Seychelles 98 99 99
Sierra Leone 90 83 78
South Africa 77 70 70
South Sudan 46 39 22
Swaziland 99 98 86
Togo 97 87 82
Uganda 93 78 82
Tanzania 99 97 99
Zambia 95 86 85
Zimbabwe 99 91 92
* 2014 WHO/UNICEF estimates.outbreaks in the recent past, we found that coverage for DTP3 vac-
cine has increased in all the 8 countries. This upward trend
observed in almost all countries in the region resulted in an
increase of the regional coverage from 5% in 1980 to 77% in
2014. Lower coverage were achieved in 2014 in Chad, Nigeria
and Cote d’Ivoire where they were 46%, 66% and 67% respectively.
The overall improvement in coverage is probably the results of
multiple factors among which strengthening capacities that have
happened during polio processes that may have been applied for
routine immunization.
It is worth to note that since 1974 when WHO launched the EPI
program to provide routine vaccinations against tuberculosis,
polio, diphtheria, tetanus, pertussis and measles to all children
[3], extraordinary progress has been made in expanding the reach
of RI programmes in Africa owing in part to several international
and regional initiatives, coupled with strong commitment by
Member States.
Data presented in this paper demonstrates significant improve-
ment of RI coverage over the years compared to the pre polio erad-
ication era denoting the potential positive contribution of polio
eradication activities to strengthening routine immunizationMCV2 OPV3 Rota_last PAB YFV
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activities from which best practices had effects on RI. The main
areas where PEI capacity improved RI were micro planning, service
delivery, program management (i.e., ‘‘polyvalent approach” and
review meetings) and capacity building (i.e., training and supervi-
sion). RI also benefited from available polio funds used to develop
guidelines.
The key role played by the support of the Gavi Alliance starting
in 2002, in strengthening RI programmes should not be over-
looked. Social mobilization component also played an important
part in the increase of vaccination coverage as communication
was a crucial component of PEI activities, successes were used to
develop integrated communication strategies for RI which were
adapted for individual countries and led to increased buy-in from
communities, so that more people participated in the campaigns.
The improvements in RI in the region demonstrate the mutual
benefit of strong RI programs have on accelerating the interruption
of poliovirus while improving access to routine vaccines. RI pro-
vided a platform for the introduction IPV, the switch from trivalent
OPV to bivalent OPV and in time the eventual withdrawal of all
OPV vaccines. PEI activities in the region increased the technical
workforce for RI programs in the region. Polio-funds enabled expe-
rienced technical EPI managers to be recruited in all countries in
the region. Having competent staff as country-level EPI managers
translated to better run immunization and surveillance programs,
including polio eradication. GPEI is currently working with the
Immunization management Group (IMG) in 10 countries targeted
by the Polio End Game Strategy for legacy planning, building on
the documented use of polio infrastructure in those countries [14].
Our review had the some limitations: Generalizing the results
of the documentation on the best practices exercise in the eight
countries beyond areas that were studied or even beyond the
country has to be performed cautiously; the identification of
respondents was not done randomly, and they were reporting on
a program that they themselves are charged with implementing
In conclusion, There is clear evidence that the huge investment
made for PEI have resulted in the interruption of wild poliovirus as
well as strengthening capacity in almost all areas of immunization
system therefore contributing substantively to the increase of
immunization coverage observed in all countries.
Despite good progress, there is still much to be done to sustain
gains made in availing vaccines, since even the best performing
countries have pockets of underserviced population. The Regional
Vaccine Action Plan 2014–2020 (RVAP) has an ambitious goal to
achieve 90% national coverage and 80% coverage in each district
of EPI vaccines by the end of the target year. Availability of ade-
quate resources remains a challenge and continued efforts are
needed to mobilize national, regional and international support
to strengthen and sustain high-quality immunization services in
African countries. Strengthening RI will in turn sustain the gains
made to eradicate poliovirus in the region and help build a stronger
system to deliver other lifesaving vaccines.
We recommend that documentation of best practices in the 8
countries to provide much more tangible results that will be
directly linked to the effect of the PEI. Countries are encouraged
to really capitalize the huge investment made during PEI in the
development of their legacy planning.We also recommend that exchange of experience from coun-
tries that have benefited with huge polio infrastructure should be
shared with others for them to beneficit from it.
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